- call +1-201-465-4211
- email sales@mrinsights.biz
Point of Care (PoC) molecular diagnostics market is poised to witness robust growth over the forecast period. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics market growth.
Scope of the Report:
Quick and precise detection of causative agents is of utmost importance in infectious disease emergency cases as the inaccuracy in disease detection leads to incorrect treatment which escalates disease spreading risk. Point of care molecular diagnostic assays permit the timely detection of the causative agent enabling effective disease control.
The global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics market by product type and applications/end industries.
Market Segment by Companies, this report covers
Abbott Laboratories
Atlas Genetics
Cepheid
Fluxergy
Roche Diagnostics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Real Time PCR
DNA/RNA Purification
Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Market Overview
1.1 Product Overview and Scope of Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics
1.2 Classification of Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics by Types
1.2.1 Global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue Comparison by Types (2017-2023)
1.2.2 Global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue Market Share by Types in 2017
1.2.3 Real Time PCR
1.2.4 DNA/RNA Purification
1.3 Global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Market by Application
1.3.1 Global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Market by Regions
1.4.1 Global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Status and Prospect (2013-2023)
1.5 Global Market Size of Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Atlas Genetics
2.2.1 Business Overview
2.2.2 Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Atlas Genetics Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Cepheid
2.3.1 Business Overview
2.3.2 Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Cepheid Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Fluxergy
2.4.1 Business Overview
2.4.2 Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Fluxergy Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Roche Diagnostics
2.5.1 Business Overview
2.5.2 Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Diagnostics Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Market Competition, by Players
3.1 Global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Players Market Share
3.2.2 Top 10 Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Players Market Share
3.3 Market Competition Trend
4 Global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Market Size by Regions
4.1 Global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Market Share by Regions
4.2 North America Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
4.3 Europe Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
4.5 South America Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
5 North America Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue by Countries
5.1 North America Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue by Countries (2013-2018)
5.2 USA Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
5.3 Canada Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
5.4 Mexico Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
6 Europe Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue by Countries
6.1 Europe Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue by Countries (2013-2018)
6.2 Germany Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
6.3 UK Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
6.4 France Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
6.5 Russia Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
6.6 Italy Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue by Countries
7.1 Asia-Pacific Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue by Countries (2013-2018)
7.2 China Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
7.3 Japan Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
7.4 Korea Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
7.5 India Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
8 South America Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue by Countries
8.1 South America Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue by Countries (2013-2018)
8.2 Brazil Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
8.3 Argentina Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
8.4 Colombia Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics by Countries
9.1 Middle East and Africa Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
9.3 UAE Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
9.4 Egypt Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
9.6 South Africa Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Growth Rate (2013-2018)
10 Global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Market Segment by Type
10.1 Global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue and Market Share by Type (2013-2018)
10.2 Global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Market Forecast by Type (2018-2023)
10.3 Real Time PCR Revenue Growth Rate (2013-2023)
10.4 DNA/RNA Purification Revenue Growth Rate (2013-2023)
11 Global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Market Segment by Application
11.1 Global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue Market Share by Application (2013-2018)
11.2 Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.5 Diagnostic Centers Revenue Growth (2013-2018)
12 Global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Market Size Forecast (2018-2023)
12.1 Global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Market Size Forecast (2018-2023)
12.2 Global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Market Forecast by Regions (2018-2023)
12.3 North America Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue Market Forecast (2018-2023)
12.4 Europe Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue Market Forecast (2018-2023)
12.6 South America Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics Picture
Table Product Specifications of Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
